Tech Daily Missouri: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Daily Missouri.

Press releases published on June 2, 2026

Jun. 2, 2026

AI กำลังเปิดตัวเร็วกว่าที่ลูกค้าจะนำไปใช้ได้ทัน ผลวิจัยใหม่ระบุ

Indeterminate GlobeNewswire

Jun. 2, 2026

最新研究发现：AI 功能发布速度超出客户采用能力

Indeterminate GlobeNewswire

Jun. 2, 2026

新研究揭示，人工智能的推出步伐已超越客戶接納的速度

Indeterminate GlobeNewswire

Jun. 2, 2026

Alvotech to present at upcoming investor conferences in June

Indeterminate GlobeNewswire

Jun. 2, 2026

Onco360® Has Been Selected as a National Specialty Pharmacy Provider for IMKELDI® (imatinib) Oral Solution

Indeterminate GlobeNewswire

Jun. 2, 2026

Tenaya Therapeutics to Announce New Interim Data from MyPEAK™-1 Phase 1b/2 Trial of TN-201 for Adults with MYBPC3-Associated HCM on Wednesday, June 3, 2026

Indeterminate GlobeNewswire

Jun. 2, 2026

Neuronetics Appoints Robert Greene as Senior Vice President Sales

Indeterminate GlobeNewswire

Jun. 2, 2026

Nanobiotix Provides First Quarter 2026 Operational and Financial Update

Indeterminate GlobeNewswire

Jun. 2, 2026

Nanobiotix fait le point sur sa tresorerie et son activite operationnelle pour le premier trimestre 2026

Indeterminate GlobeNewswire

Jun. 2, 2026

Microchip Technology to Present at the 2026 Evercore Global TMT Conference

Indeterminate GlobeNewswire

Jun. 2, 2026

Crescent Biopharma to Present at June Investor Conferences

Indeterminate GlobeNewswire

Jun. 2, 2026

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 2, 2026

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 2, 2026

Crinetics and Leading Patient Groups Launch ‘Everyday Advocacy’ Initiative to Empower People Across Endocrine Disease Communities

Indeterminate GlobeNewswire

Jun. 2, 2026

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 2, 2026

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 2, 2026

Netskope Joins Anthropic’s Project Glasswing

Indeterminate GlobeNewswire

Jun. 2, 2026

Duos Technologies Receives $50.4 Million from APR Energy Asset Sale

Indeterminate GlobeNewswire

Jun. 2, 2026

Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution

Indeterminate GlobeNewswire

Jun. 2, 2026

Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults

Indeterminate GlobeNewswire